DCOY
DCOY
NASDAQ · Biotechnology

Decoy Therapeutics Inc

$0.98
-0.08 (-7.56%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,466.2% upside
Low Target $37.12
Average Target $44.53
High Target $63.68
Current Price $0.98
Current
$0.98
Target
$44.53
$37.12 $44.53 avg $63.68
Scenario Analysis
Bear Case
$37.12
3,706.4%
Low target
Base Case
$44.53
+4,466.2%
Avg target
Bull Case
$63.68
+6,429.9%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$20.76
-95.3% from high
52-Week Low
$0.90
+8.4% from low
Target vs 52W High
$44.53
+114.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%